Johnson Financial Group, Inc. Intra Cellular Therapies, Inc. Transaction History
Johnson Financial Group, Inc.
- $2.05 Billion
- Q4 2024
A detailed history of Johnson Financial Group, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 69 shares of ITCI stock, worth $8,873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 88
21.59%
Holding current value
$8,873
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
416Shares Held
88.5MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.25 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$813 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$659 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$418 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$413 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.1B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...